• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活物受体:一种多功能信号协调因子。

uPAR: a versatile signalling orchestrator.

作者信息

Blasi Francesco, Carmeliet Peter

机构信息

Department of Molecular Biology and Functional Genomics, DIBIT, Università Vita Salute San Raffaele, Via Olgettina 58, 20132 Milano, Italy.

出版信息

Nat Rev Mol Cell Biol. 2002 Dec;3(12):932-43. doi: 10.1038/nrm977.

DOI:10.1038/nrm977
PMID:12461559
Abstract

The plasminogen system has been implicated in clot lysis, wound healing, tissue regeneration, cancer and many other processes that affect health and disease. The urokinase receptor uPAR was originally thought to assist the directional invasion of migrating cells, but it is now becoming increasingly evident that this proteinase receptor elicits a plethora of cellular responses that include cellular adhesion, differentiation, proliferation and migration in a non-proteolytic fashion.

摘要

纤溶酶原系统与血栓溶解、伤口愈合、组织再生、癌症以及许多其他影响健康和疾病的过程有关。尿激酶受体uPAR最初被认为有助于迁移细胞的定向侵袭,但现在越来越明显的是,这种蛋白酶受体以非蛋白水解的方式引发了大量细胞反应,包括细胞黏附、分化、增殖和迁移。

相似文献

1
uPAR: a versatile signalling orchestrator.尿激酶型纤溶酶原激活物受体:一种多功能信号协调因子。
Nat Rev Mol Cell Biol. 2002 Dec;3(12):932-43. doi: 10.1038/nrm977.
2
Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.尿激酶型纤溶酶原激活剂系统与整合素的分子及功能相互依存关系。
Biol Chem. 2003 Aug;384(8):1119-31. doi: 10.1515/BC.2003.125.
3
Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.白细胞介素-1α通过调节α6β1整合素和尿激酶型纤溶酶原激活剂受体的表达增强胰腺癌细胞的侵袭行为。
BMC Cell Biol. 2006 Feb 20;7:8. doi: 10.1186/1471-2121-7-8.
4
Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.尿激酶型纤溶酶原激活物受体的表达与舌鳞状细胞癌的转移相关。
Br J Oral Maxillofac Surg. 2006 Dec;44(6):515-9. doi: 10.1016/j.bjoms.2005.10.009. Epub 2005 Dec 13.
5
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.靶向人胰腺癌细胞中的尿激酶型纤溶酶原激活物受体可抑制c-Met和胰岛素样生长因子-I受体介导的迁移、侵袭以及小鼠原位肿瘤生长。
Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946.
6
[Interaction of urokinase-type plasminogen activator receptor with integrins during cell adhesion and migration].[尿激酶型纤溶酶原激活物受体在细胞黏附和迁移过程中与整合素的相互作用]
Postepy Biochem. 1999;45(2):109-16.
7
The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.尿激酶受体与玻连蛋白在细胞黏附及信号传导中的相互作用
Eur J Cell Biol. 2008 Sep;87(8-9):617-29. doi: 10.1016/j.ejcb.2008.02.003. Epub 2008 Mar 18.
8
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.尿激酶受体(uPAR)和uPAR相关蛋白(uPARAP/Endo180):在组织重塑过程中参与基质周转的膜蛋白。
Biol Chem. 2004 Feb;385(2):103-36. doi: 10.1515/BC.2004.031.
9
Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.模拟胞外域亲和力对膜受体空间分布的影响。
J Theor Biol. 1999 Mar 21;197(2):217-25. doi: 10.1006/jtbi.1998.0869.
10
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.通过尿激酶连接肽区域与αvβ5整合素之间的新型相互作用激活尿激酶受体。
J Cell Sci. 2006 Aug 15;119(Pt 16):3424-34. doi: 10.1242/jcs.03067. Epub 2006 Aug 1.

引用本文的文献

1
5-Aminolevulinic acid-mediated photodynamic therapy improves scar healing of laryngeal wounds in rats.5-氨基酮戊酸介导的光动力疗法改善大鼠喉部伤口的瘢痕愈合。
Lasers Med Sci. 2025 Sep 9;40(1):353. doi: 10.1007/s10103-025-04588-4.
2
Inhibiting The uPA/uPAR Pathway Affords Photoreceptor Resilience and Preserves Retinal Function in a Mouse Model of Retinitis Pigmentosa.在视网膜色素变性小鼠模型中,抑制尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体(uPA/uPAR)通路可增强光感受器的恢复能力并保留视网膜功能。
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):29. doi: 10.1167/iovs.66.11.29.
3
The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma.
尿激酶受体/uPAR是吉西他滨治疗的胰腺导管腺癌中p53功能获得性突变的主要效应分子。
J Biol Chem. 2025 Aug 7;301(9):110561. doi: 10.1016/j.jbc.2025.110561.
4
uPAR and cFn as candidate protein biomarkers for identifying low response to rtPA in acute ischemic stroke.尿激酶型纤溶酶原激活物受体(uPAR)和纤连蛋白(cFn)作为急性缺血性卒中患者对重组组织型纤溶酶原激活剂(rtPA)反应低下的候选蛋白质生物标志物。
Eur J Med Res. 2025 Jul 24;30(1):662. doi: 10.1186/s40001-025-02772-4.
5
GPLD1 Attenuates Heart Failure via Dual-Membrane Localization to Inhibit uPAR.GPLD1通过双膜定位抑制uPAR减轻心力衰竭。
Circ Res. 2025 Aug 15;137(5):e124-e143. doi: 10.1161/CIRCRESAHA.124.325623. Epub 2025 Jul 9.
6
PINLYP-mediated phospholipid metabolism reprogramming contributes to chronic herpesvirus infection.PINLYP介导的磷脂代谢重编程促成慢性疱疹病毒感染。
PLoS Pathog. 2025 May 15;21(5):e1013146. doi: 10.1371/journal.ppat.1013146. eCollection 2025 May.
7
The crosstalk of breast cancer and ischemic heart disease.乳腺癌与缺血性心脏病的相互影响
Cell Death Discov. 2025 Apr 18;11(1):185. doi: 10.1038/s41420-025-02428-6.
8
A spatially resolved transcriptome landscape during thyroid cancer progression.甲状腺癌进展过程中的空间分辨转录组图谱。
Cell Rep Med. 2025 Apr 15;6(4):102043. doi: 10.1016/j.xcrm.2025.102043. Epub 2025 Mar 28.
9
Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome.特发性肾病综合征中循环因子和生物标志物的既往及未来体外和体内研究方法
Pediatr Nephrol. 2025 Jan 30. doi: 10.1007/s00467-024-06643-8.
10
Radiopharmaceuticals and their applications in medicine.放射性药物及其在医学中的应用。
Signal Transduct Target Ther. 2025 Jan 3;10(1):1. doi: 10.1038/s41392-024-02041-6.